ABSTRACT NUMBER: ESOC2026A1191 LONGITUDINAL CHANGES IN SERUM ENDOTHELIN-1 AND INTERLEUKIN-6 FOLLOWING ACUTE ISCHEMIC STROKE AND REVASCULARIZATION THERAPIES

Abstract Background and aims Post-reperfusion complications remain common after ischemic stroke. Biomarkers may clarify mechanisms and identify high-risk patients. We evaluated serum Endothelin-1(Et-1) and Interleukin-6 (IL6), comparing patients by revascularization therapy. Methods We enrolled imaging-confirmed ischemic stroke patients (18-80 years, onset <24h, NIHSS>1, pre-stroke mRS<2). Those with prior neurological disease, immunosuppression, pregnancy, or severe renal failure were excluded. Twelve healthy controls were considered. Et-1 and IL6 were determined with Ella on samples collected within 24h (T0), 3-5d (T1) and 7±2d (T2). Results Ninety-eight patients were enrolled (59M, median age 68.4y[IQR58.6-74.1]). At onset, NIHSS was 1-4 in 58.2%, 5-15 in 32.7%, >16 in 9.1%; 44.9% underwent no procedures (NRP), 33.7% thrombolysis (IVT), 11.2% endovascular thrombectomy (EVT), 10.2% IVT+EVT. Et-1 was higher at T0 vs. controls, T1 and T2 (Fig1A); IL6 at T0 vs. controls (Fig. 1B). Between revascularization groups, Et-1 was higher in EVT vs. NRP at T0 and T1 (Fig1C), while IL6 only at T0 (Fig1D). Higher Et-1 and IL6 at T0 were independently associated with lower-odds of good outcome (mRS 0-2) at 90d (Et-1:aOR 0.43, 95%CI 0.25-0.74; IL6:aOR 0.95, 95%CI 0.90-1.00). Only Et-1 was independently associated with lower odds of full recovery to pre-stroke functional status (aOR 0.69, 95%CI 0.51-0.93). Conclusions Et-1 and IL6 peak 24h after stroke, being higher in EVT, with prognostic relevance diverging: IL6 is associated to worse outcome, whereas Et-1 may reflect mechanisms that hinder full neurological recovery. Funding. Ricerca Corrente (IRCCS-Mondino). Conflict of interest Ferrari Federica: nothing to disclose; Loizzo Nicola: nothing to disclose; Mazzacane Federico: nothing to disclose; Del Bello Beatrice: nothing to disclose; Scaranzin Silvia: nothing to disclose; Morandi Chiara: nothing to disclose; Gastaldi Matteo: nothing to disclose; Persico Alessandra: nothing to disclose; Cavallini Anna: nothing to disclose Figure 1 - belongs to Results

Authors

Institutions

Publication Details

Journal
European Stroke Journal
Published
2026-05-01
DOI
https://doi.org/10.1093/esj/aakag023.590
Primary Topic
Acute Ischemic Stroke Management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

ABSTRACT NUMBER: ESOC2026A1191 LONGITUDINAL CHANGES IN SERUM ENDOTHELIN-1 AND INTERLEUKIN-6 FOLLOWING ACUTE ISCHEMIC STROKE AND REVASCULARIZATION THERAPIES

Beatrice Del Bello, Alessandra Persico, Silvia Scaranzin, Federico Mazzacane et al.
European Stroke Journal
Acute Ischemic Stroke Management
article

ABSTRACT NUMBER: ESOC2026A1191 LONGITUDINAL CHANGES IN SERUM ENDOTHELIN-1 AND INTERLEUKIN-6 FOLLOWING ACUTE ISCHEMIC STROKE AND REVASCULARIZATION THERAPIES

Beatrice Del Bello, Alessandra Persico, Silvia Scaranzin, Federico Mazzacane, Chiara Morandi, Federica Ferrari, Matteo Gastaldi, Anna Cavallini, Nicola Loizzo
article en

Abstract

Abstract Background and aims Post-reperfusion complications remain common after ischemic stroke. Biomarkers may clarify mechanisms and identify high-risk patients. We evaluated serum Endothelin-1(Et-1) and Interleukin-6 (IL6), comparing patients by revascularization therapy. Methods We enrolled imaging-confirmed ischemic stroke patients (18-80 years, onset <24h, NIHSS>1, pre-stroke mRS<2). Those with prior neurological disease, immunosuppression, pregnancy, or severe renal failure were excluded. Twelve healthy controls were considered. Et-1 and IL6 were determined with Ella on samples collected within 24h (T0), 3-5d (T1) and 7±2d (T2). Results Ninety-eight patients were enrolled (59M, median age 68.4y[IQR58.6-74.1]). At onset, NIHSS was 1-4 in 58.2%, 5-15 in 32.7%, >16 in 9.1%; 44.9% underwent no procedures (NRP), 33.7% thrombolysis (IVT), 11.2% endovascular thrombectomy (EVT), 10.2% IVT+EVT. Et-1 was higher at T0 vs. controls, T1 and T2 (Fig1A); IL6 at T0 vs. controls (Fig. 1B). Between revascularization groups, Et-1 was higher in EVT vs. NRP at T0 and T1 (Fig1C), while IL6 only at T0 (Fig1D). Higher Et-1 and IL6 at T0 were independently associated with lower-odds of good outcome (mRS 0-2) at 90d (Et-1:aOR 0.43, 95%CI 0.25-0.74; IL6:aOR 0.95, 95%CI 0.90-1.00). Only Et-1 was independently associated with lower odds of full recovery to pre-stroke functional status (aOR 0.69, 95%CI 0.51-0.93). Conclusions Et-1 and IL6 peak 24h after stroke, being higher in EVT, with prognostic relevance diverging: IL6 is associated to worse outcome, whereas Et-1 may reflect mechanisms that hinder full neurological recovery. Funding. Ricerca Corrente (IRCCS-Mondino). Conflict of interest Ferrari Federica: nothing to disclose; Loizzo Nicola: nothing to disclose; Mazzacane Federico: nothing to disclose; Del Bello Beatrice: nothing to disclose; Scaranzin Silvia: nothing to disclose; Morandi Chiara: nothing to disclose; Gastaldi Matteo: nothing to disclose; Persico Alessandra: nothing to disclose; Cavallini Anna: nothing to disclose Figure 1 - belongs to Results

European Stroke JournalVol. 11(Supplement_1)
Università degli Studi del Piemonte Orientale “Amedeo Avogadro” (IT), University of Pavia (IT), Foundation Center (US), Fondazione Istituto Neurologico Nazionale Casimiro Mondino (IT), Urology Foundation (GB)
Good health and well-being
Openalex Percentile: Top 10%
Acute Ischemic Stroke Management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.